Jusmiral Holdings Limited, a promoter of Cohance Lifesciences, has sold 3,41,48,000 shares, reducing its stake to 24.15%. The sale occurred on September 18, 2025. The proceeds are primarily intended for part payment of borrowings under the Notes Purchase Agreement. This disclosure follows insider trading regulations and provides information regarding changes in promoter holdings.
Promoter Share Sale
Jusmiral Holdings Limited, a promoter of Cohance Lifesciences, executed a sale of shares on September 18, 2025. The transaction involved the disposal of 3,41,48,000 shares.
Revised Shareholding
Following the sale, Jusmiral Holdings Limited’s shareholding in Cohance Lifesciences has decreased to 24.15%. The company previously held 33.08% of the shares.
Use of Proceeds
The proceeds from the sale are primarily intended to be used for the partial repayment of borrowings under the Notes Purchase Agreement. The initial disclosures related to this agreement were made on May 9, 2025.
Source: BSE
